Supplementary figures from β-Catenin Is a Candidate Therapeutic Target for Myeloid Neoplasms with del(5q)

Authors :: Zhijian Qian
Tongyu Zhu
Howard Ozer
You-Yang Zhao
Amber Seba
Kaoru Tohyama
Nupur Mittal
Chao Hu
Wenshu Li
Yue Sheng
Liping Li
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental Figure 1. Indo suppresses beta-catenin expression. (A) Luciferase reporter assay of beta-catenin transcription activity. (B) beta-catenin expression in MDSL and UoC-M1 cells after Indo treatment for 72 hours. *, P

Tools